Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Licenses Kreatech's ULS Labeling Tech for Use With aCGH Platform

NEW YORK (GenomeWeb News) — Agilent Technologies has licensed labeling technology from Kreatech for use with its formalin-fixed paraffin-embedded DNA tissue-extraction method, Agilent said today.
Agilent said it will use Kreatech’s Universal Linkage System, which is a non-enzymatic direct-labeling methodology that has been optimized to be used with Agilent’s oligo comparative genomic hybridization microarrays.
There are around 400 million FFPE-preserved DNA samples in tissue banks that are “too degraded to use in microarray analysis techniques such as aCGH,” the company said. 
Having the capability to access degraded FFPE samples for microarray use offers “tremendous promise for cancer researchers,” Jay Kaufman, Agilent’s marketing director, said in a statement.
Financial terms of the agreement were not released.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.